tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Mural Oncology to discontinue nemvaleukin development, reduce staff by 90%
PremiumThe FlyMural Oncology to discontinue nemvaleukin development, reduce staff by 90%
4M ago
Mural Oncology plans to explore strategic alternatives
Premium
The Fly
Mural Oncology plans to explore strategic alternatives
4M ago
Mural Oncology price target lowered to $6 from $18 at H.C. Wainwright
Premium
The Fly
Mural Oncology price target lowered to $6 from $18 at H.C. Wainwright
5M ago
Mural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe FlyMural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley
5M ago
Premium
Ratings
Promising Developments in Mural Oncology Plc’s ARTISTRY-7 Trial Boost Buy Rating
5M ago
Premium
Ratings
Promising Outlook for Mural Oncology: Buy Rating Driven by Nemvaleukin’s Potential and Strategic Trials
5M ago
PremiumCompany AnnouncementsMural Oncology Advances Drug Pipeline and Extends Runway
7M ago
Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
9M ago
Mural Oncology files $300M mixed securities shelf
Premium
The Fly
Mural Oncology files $300M mixed securities shelf
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100